| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb2648e65ad8850515bd727a122f1186
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88c4455df03bb049a51012a73c723ce2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-22084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2020-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6198df85df0e0c4624fa999b1c4604cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc8a3dd3cd7512ad45c65f39165d898f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b7e9b944de0c379c62d447582892d86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52af18c3e80d53a6a9578069c343c71f |
| publicationDate |
2021-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-102020018623-A2 |
| titleOfInvention |
ARGONIUM COMBINED WITH THROMBECTOMY IN CASE OF ISCHEMIC BRAIN VASCULAR ACCIDENT |
| abstract |
The invention relates to an inhalable gaseous drug containing argon gas for use in combination with a mechanical thrombectomy to treat, reduce or resorb brain injuries following an ischemic stroke in an individual. Preferably, the volume ratio of argon is between 30 and 79%. Mechanical thrombectomy may be accompanied by drug-based thrombolysis to dissolve the clot and thin the patient's blood. |
| priorityDate |
2019-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |